INS and type 1 diabetes mellitus: In a small pilot study of 18 patients (11 males and seven females), pediatric patients who had newly diagnosed type 1 diabetes and who were treated with etanercept had lower A1C and increased endogenous insulin production, suggesting preservation of beta-cell function.